Flucytosine Monotherapy for Cryptococcosis
Authors:
- John E. BennettJBJohn E. Bennett
Open Access
- 1 August 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 27 (2) , 260-264
Abstract
Flucytosine (5-FC) monotherapy for cryptococcosis is not advocated because drug resistance emerges during therapy. Reported documentation of this widKeywords
This publication has 3 references indexed in Scilit:
- European experience with itraconazole in systemic mycosesJournal of the American Academy of Dermatology, 1990
- Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitisThe American Journal of Medicine, 1987
- Prognostic Factors in Cryptococcal MeningitisAnnals of Internal Medicine, 1974